Advertisement

Die Infektion mit Enteroviren

  • Hilt Lennartz
Conference paper
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 20)

Zusammenfassung

In den letzten 10 Jahren ist in Amerika und Europa keiner Viruserkrankung mehr Beachtung geschenkt worden als der Poliomyelitis (im internationalen Schrifttum abgekürzt: Polio). Obgleich die ersten virologischen Untersuchungen bereits 1909 von Landsteiner (97) durchgeführt wurden, sind wesentliche neue Erkenntnisse erst auf Grund moderner Laboratoriumstechniken in den letzten 20 Jahren in erster Linie in den Vereinigten Staaten gewonnen worden. Die Virus-forschung war bis 1949 ausschließlich auf Tierversuche, vor allem mit Hühner embryonen und auf Plasmaclot-Gewebekulturen angewiesen. Dann folgte mit der von Enders (39) eingeführten Gewebekultur und dem Gebrauch von Antibiotica in der Gewebekultur ein großer Aufschwung in der experimentellen und angewandten Virologie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Academy of Medical Sciences, U.S.S.R. Institute for Polio myelitis Research: The main results of the IV. scientific conference of the institute and the international symposium 1st Soviet-American discussion of problems relating to the control of poliomyelitis, pp. 3–20. Moscov 1960.Google Scholar
  2. 2.
    Archetti, J. A., A. Felici, F. Russi and C. Fua: Researches, on the etiologic agent of the marche meningo neuraxitis during the epidemic outbreak of the summer and autumn of 1955. Sci. med. ital. 5, 321 (1956).Google Scholar
  3. 3.
    Archetti, J. A., Cited in D. Dalldorf: Brief review of Coxsackie viruses. Ann. N. Y. Acad. Sci. 67, 209–211 (1957).CrossRefGoogle Scholar
  4. 4.
    Armstrong, C.: The experimental transmission of poliomyelitis to the eastern cotton rat. Publ. Hlth. Rep. (Wash.) 54, 1719–1721 (1939).CrossRefGoogle Scholar
  5. 5.
    Barski, G., P. Lépine, V. Monaci et G. de Brion: Culture in vitro de la Poliomyelitis en presence de tissue tonsillaire humain. Ann. Inst. Pasteur 84, 825–840 (1953).Google Scholar
  6. 6.
    Barski, G., Multiplication of poliomyelitis virus in reticuloendothelial cells without generalized cytopathogenic effect. Science 125, 448 (1957).PubMedCrossRefGoogle Scholar
  7. 7.
    Bauer, H., R. N. Barr, H. Kleinman, A. C. Kimball, M. K. Cooney, J. E. Bearman and W. E. Mathey: 3. Occurrence of Viremia. Live Poliovirus Vaccines, World Health Org., Washington, D. C. 1960, 357 (1960).Google Scholar
  8. 8.
    Beemann, E., E. A. Beeman, R. H. Parrot and R. M. Cole: Simultaneous occurence of two immunological types of group A Coxsackie virus in a case of herpangina. Proc. Soc. Exp. Biol. (N. Y.) 78, 295 (1951).Google Scholar
  9. 9.
    Blattner, R. J.: Acute aseptic myocarditis in the newborn infant. J. Pediat. 50, 644 (1957).CrossRefGoogle Scholar
  10. 10.
    Bodian, D.: The virus, the nerve cell and paralysis. Bull, the Johns Hopk. Hosp. 83, 1704 (1948).Google Scholar
  11. 11.
    Bodian, D., J. M. Morgan and H. A. Howe: Differentiation of types of poliomyelitis viruses. III. The grouping of fourteen strains into three basic immunological types. Amer. J. Hyg. 60, 83–92 (1949).Google Scholar
  12. 12.
    Bodian, D., and H. A. Howe: A Reconsideration of the pathogenesis of poliomyelitis. Amer. J. Hyg. 55, 414 (1952).PubMedGoogle Scholar
  13. 13.
    Bodian, D., Pathogenesis of poliomyelitis. Amer. J. publ. Hlth. 42, 1388 (1952).CrossRefGoogle Scholar
  14. 14.
    Bodian, D., Emering concept of poliomyelitis infection. Science 122, 105 (1955).PubMedCrossRefGoogle Scholar
  15. 15.
    Bodian, D., Mechanism of infection with poliomyelitis virus in cellular biology, nucleic acid and viruses. N. Y. Acad. Sci. Special publication pp. 57–75 (1957).Google Scholar
  16. 16.
    Brohl, J., K. Helmstaedt, H. Lennartz and G. Maass: Über eine Epidemie von Coxsackie-Meningitis. Z. ärztl. Fortbild. 51, 499 (1957).Google Scholar
  17. 17.
    Le Bouvier, G. L.: Interference and cell protection by poliomyelitis virus in tissue culture. Nature (Lond.) 174, 649–651 (1954).CrossRefGoogle Scholar
  18. 18.
    Cardelle, G., R. Martin Jiménez, J. Embil jr. and F. Cao: Herpangina. (Report of 43 cases and isolation of Coxsackie virus). Rev. cuba. Pediat. 26, 703 (1954).Google Scholar
  19. 19.
    Curnen, E. C., A. H. London jr., E. Tanabe, W. P. Glezen and J. Koomen: An epidemic of aseptic meningitis attributable to Coxsackie B5-Virus. Amer. J. Dis. Child. 96, 571–73 (1958).Google Scholar
  20. 20.
    Chin, T. D. Y.: Discussion Part. III. Ann. N. Y. Acad. Sci. 67, 354 (1957).Google Scholar
  21. 21.
    Chumacov, M. P., and K. M. Voroshilova: Poliomyelitis-like properties of AB-IV. Coxsackie A 7 Group of Viruses. Progr. med. Virol. 2, 106 (1959).Google Scholar
  22. 22.
    Committee on the ECHO Viruses. Science. 122, 1187 (1955).CrossRefGoogle Scholar
  23. 23.
    Committee on the ECHO Viruses. Amer. J. Publ. Hlth. 47, 1556 (1957).CrossRefGoogle Scholar
  24. 24.
    Committee on the Enteroviruses. The Enteroviruses. Amer. J. Pupl. Hlth. 47, 1556–1566 (1957).Google Scholar
  25. 25.
    The Committee on Typing of the national Fundation for Infantile Paralysis. Immunologic classification of poliomyelitis viruses. Amer. J. Hyg. 54, 191–274 (1951).Google Scholar
  26. 26.
    Cramer, R.: Verhalten von Plasmocytomzellkulturen nach Beimpfung mit Poliomyelitis- virus aller drei Typen. Experientia (Basel) XII, Fase. 5, 165–205 (1956).Google Scholar
  27. 27.
    Cramer, R. and S. Franzen: On the absence of a cytopathogenic effect of the three poliomyelitis virus types on plasmacytoma cells and macrophages in bone marrow cultures. Arch. ges. Virusforsch. 7, 461–470 (1957).PubMedCrossRefGoogle Scholar
  28. 28.
    van Crefeld, S., and H. de Jager: Myocarditis in newborn caused by Coxsackie virus. Clinical and pathological data. Ann. paediat. (Basel) 187, 100 (1956).Google Scholar
  29. 29.
    Dalldorf, G., and G. M. Sickles: An unidentified, filtrable agent isolated from the feces of children. Science 108, 61–62 (1948).PubMedCrossRefGoogle Scholar
  30. 30.
    Dalldorf, G., The sparing effect of Coxsackie virus infection on experimental poliomyelitis. J. exp. Med. 94, 65 (1951).PubMedCrossRefGoogle Scholar
  31. 31.
    Dalldorf, G., and R. Albrecht: Chronologic association of poliomyelitis and Coxsackie virus infections. Proc. nat. Acad. Sci. (Wash.) 41, 978–982 (1955).CrossRefGoogle Scholar
  32. 32.
    Dalldorf, G., and H. Weigand: Poliomyelitis as a complex infection. J. exp. Med. 108, 605 (1958).PubMedCrossRefGoogle Scholar
  33. 33.
    Dalldorf, G., Neuropathogenicity of Group A Coxsackie viruses. J. exp. Med. 106, 69–76 (1959).CrossRefGoogle Scholar
  34. 34.
    Dalldorf, G., J. L. Melnick and E. C. Curnen: The Coxsackie virus group. Viral and Rickettsial infections of man Pitman Medical Publishing Co., 519. Ltd. London 1959.Google Scholar
  35. 35.
    Dauer, C. C.: The changing age distribution of paralytic poliomyelitis: the biology of poliomyelitis. Ann. N. Y. Acad. Sci. 61, 943–955 (1955).PubMedCrossRefGoogle Scholar
  36. 36.
    Davis, D. C., and J. L. Melnick: Association of ECHO virus type 6 with aseptic meningitis. Proc. Soc. exp. Biol. Med. N. Y.) 92, 839 1956 ).Google Scholar
  37. 37.
    Dunham, W. B.: Propagation of poliomyelitis virus in chik embryo cell cultures. I. Cultivation of three virus types. Proc. Soc. exp. Biol. (N. Y.) 95, 637–639 (1957).Google Scholar
  38. 38.
    Eichenwald, H. F., B. A. Ababio, A. M. Arky and A. P. Hartmann: Epidemic diarrhoea in premature and older infants caused by ECHO virus type 18. J. Amer, med. Ass. 166, 1563 (1958).CrossRefGoogle Scholar
  39. 39.
    Enders, J. F., T. H. Weller and F. C. Robbins: Cultivation of the Lansing strain of poliomyelitis virus in cultures of various human embryonic tissues. Science 109, 85–87 (1949).PubMedCrossRefGoogle Scholar
  40. 40.
    Enders-Ruckle, G., and R. Siegert: Virusausscheidung und Antikörperentwicklung nach Anwendung eines trivalenten Poliomyelitis-Lebendimpfstoffes (Cox-Lederle). Teil I: Dtsch. med. Wschr. 86, 42 1999 (1961); Teil II: Dtsch. med. Wschr. 86, 43, 2060–1062 (1961).CrossRefGoogle Scholar
  41. 41.
    Faber, H. K.: The pathogenesis of poliomyelitis. Pediatrics 17, 278 (1956).PubMedGoogle Scholar
  42. 42.
    Fletcher, E., and C. F. Brennan: Cardiac complications of Coxsackie-virus infection. Lancet 1957 I, 913.Google Scholar
  43. 43.
    Fox, J. P., H. M. Gelfand, P. N. Bhatt, D. R. Le Blanc and D. P. Conwell: Immunizing infections with poliomyelitis viruses and sero immune patterns in Southern Louisiana. Ann. N. Y. Acad. Sci. 61, 968 (1955).PubMedCrossRefGoogle Scholar
  44. 44.
    Fox, J. P., H. M. Gelfand, D. R. Leblanc and D. P. Convell: Studies on the development of natural immunity to poliomyelitis in Louisiana. Amer. J. Hyg. 65, 344 (1957).PubMedGoogle Scholar
  45. 45.
    Fox, J. P., Influence of natural and artificially induced immunity on alimentary infection with poliomyelitis virus. Amer. J. publ. Hlth. 48, 1181–1192 (1958).CrossRefGoogle Scholar
  46. 46.
    Francis, T. jr., J. A. Napier, R. B. Voigt’h, F. M. Hemphill, H. A. Wenner, R. F. Korns, B. A. Boisen, E. Tolchinsky and E. L. Diamond: Evaluation of the 1954 field trial of poilomyelitis vaccine. Final report. Edwards Bros. Inc. Ann. Arbor, Michigan (1957).Google Scholar
  47. 47.
    Francis, T. jr., J. A. Napier, R. B. Voigt’h, F. M. Hemphill, H. A. Wenner, R. F. Korns, B. A. Boisen, E. Tolchinsky and E. L. Diamond: Evaluation of the 1954 field trial of poliomyelitis vaccine (final-report). Amer. J. Pvbl. Hlth. 45, No. 5 (1957).Google Scholar
  48. 48.
    Gabinus, O., S. Gard, T. Johnsson and A. Pöldre: Studies on the etiology of epidemic pleurodynia (Bornholm-disease). I. Clinical and virological observation. Arch. ges. Virusforsch. 5, 1 (1952).Google Scholar
  49. 49.
    Gard, S.: The etiology of acute aseptic meningitis. Acta paediat. (Uppsala) 43, 54–64 (1954).CrossRefGoogle Scholar
  50. 50.
    Gear, J., V. Masroch, and F. R. Prinzloo: The medical and public health importance of the Coxsackie viruses. S. Afr. med. J. 30, 806 (1956).PubMedGoogle Scholar
  51. 51.
    Gear, J., Discussion live polio virus vaccines. No. 1. W. H. O. Washington 1959.Google Scholar
  52. 52.
    Gifford, R., and G. Dalldorf: The morbid anatomy of experimental Coxsackie virus infection. Amer. J. Path. 27, 1047 ( 1951.PubMedGoogle Scholar
  53. 53.
    Giradi, A. J., K. Hummeler and J. Olchin: Aseptic meningitis caused by Coxsackie virus with isolation of virus caused by cerebrospinal fluid. J. Amer. med. Ass. 156 676–697 (1954).CrossRefGoogle Scholar
  54. 54.
    Grist, N. R.: Isolation of Coxsackie virus in Scotland. Lancet 7133, 1054 (1960).CrossRefGoogle Scholar
  55. 55.
    Godtfredsen, A.: Strain of Coxsackie virus type A9 and ECHO virus type 9 from cerebrospinal fluids. Acta path. microbiol. scand. 46, 217 (1959).PubMedCrossRefGoogle Scholar
  56. 56.
    Habel, K., R. J. Silverberg and A. Shelokov: Isolation of enteric viruses from cases of aseptic meningitis. Ann. N. Y. Acad. Sci. 67, 223–229 (1957).PubMedCrossRefGoogle Scholar
  57. 57.
    Habel, K. and L. N. Loonis: Coxsackie A7 virus and the Russian Poliovirus Type 4. Proc. Soc. exp. Biol. (N. Y.) 95, 597 (1957).Google Scholar
  58. 58.
    Hammon, W. McD., L. L. Coriell, P. F. Wehrle and J. Stokes jr.: Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. J. Amer. med. Ass. 151, 1272 (1953).Google Scholar
  59. 59.
    Hammon, W. McD and E. H. Ludwig: Possible protective effect of previous type II infection against paralytic poliomyelitis due to type I virus. Amer. J. Hyg. 66, 274 (1957).PubMedGoogle Scholar
  60. 60.
    Hammon, W. McD., E.H. Ludwig, R. A. Pavia, L. W. McCloskey and G. E. Sather: Problems raised by certain ECHO-viruses in the attempted laboratory detection of poliomyelitis virus infection. Ann. N. Y. Acad. Sci. 67, 305 (1957).CrossRefGoogle Scholar
  61. 61.
    Hammon, W. McD., A Study of certain nonpoliomyelitis and poliomyelitis enterovirus infections. J. Amer. med. Ass. 167, 727 (1958).CrossRefGoogle Scholar
  62. 62.
    Hammon, W. McD., Isolation and characterization of prototype viruses E 26, 27 and Coxsackie B 6. Proc. Soc. exp. Biol. (N. Y.) 108, 164 (1960).Google Scholar
  63. 63.
    Hemmes, J. H., H. C. Winkler and S. M. Kool: Virus survival as a aseasonal factor in influenza and poliomyelitis. Nature (Lond.) 188, 430 (1960).CrossRefGoogle Scholar
  64. 64.
    Henigst, W., J. P. Fox and H. M. Gelfand: Über die Ausbreitung des Poliomyelitis-virus und anderer im menschlichen Stuhl auftretender Viren. Münch, med. Wschr. 99, 1117 (1957).Google Scholar
  65. 65.
    Henigst, W., Beitrag der Epidemiologie der Echo-Viren. Dtsch. med. Wschr. 84, 1022 (1959).PubMedCrossRefGoogle Scholar
  66. 66.
    Höring, F. O.: Klinische Infektions-Lehre. 80. Berlin-Göttingen-Heidelberg: Springer- Verlag 1938.Google Scholar
  67. 67.
    Horstmann, D. M., and E. E. Manuelidis: New Russian virus. Fed. Proc. 16, 418 (1957).Google Scholar
  68. 68.
    Horstmann, D. M., and E. E. Manuelidis: Russian Coxsackie A7 virus (AB IV strain) neuropathogenicity and comparison with polio virus. J. Immunol. 81, 32–42 (1958).PubMedGoogle Scholar
  69. 69.
    Horstmann, D. M., J. C. Niedermann and J. R. Powel: Attenuated type I polio virus Vaccine. J. Amer. med. Ass. 170, 1 (1959).CrossRefGoogle Scholar
  70. 70.
    Horstmann, D. M., Report on a visit to the U.S.S.R., Poland and Czechoslovakia to review work on live polio vaccine August-October 1959. From the Section of Epidemiology and Preventive Medicine and the Department of Pediatrics, Yale University School of Medicine, New Haven, Conn. USA. 1960.Google Scholar
  71. 71.
    Howitt, B. J.: Recovery of Coxsackie group of viruses from human sources. Proc. Soc. exp. Biol. (N. Y.) 73, 443 (1950).Google Scholar
  72. 72.
    Howitt, B. J. and V.J. Nichols: Inoculation of eynomolgus monkeyes with Coxsackie virus alone, combined or with poliomyelitis virus. J. Immunol. 68, 599–608 (1952).PubMedGoogle Scholar
  73. 73.
    Hsiung, G. D., and J. L. Melnick: Morphologic characteristics of plaques produced on monkey kidney monomayer cultures by enteric viruses (Poliomyelitis, Coxsackie, Echo). J. Immunol. 78, 128 (1957).PubMedGoogle Scholar
  74. 74.
    Hsiung, G. D., Comparative susceptibility of kidney cells from different monkey species to enteric viruses (Poliomyelitis, Coxsackie, ECHO) J. Immunol. 78, 137–146 (1957).PubMedGoogle Scholar
  75. 75.
    Huebner, R. J., R. M. Cole, E. A. Beeman, J. A. Bell and J. H. Peers: Herpangina disease. Etiological studies of a specific infection. J. Amer. med. Ass. 145, 628–633 (1951).CrossRefGoogle Scholar
  76. 76.
    Huebner, R. J., Epidemic pleurodynia in Texas. New Engl. J. Med. 248, 267 (1953).Google Scholar
  77. 77.
    Hurst, E. W., and R. W. Fairbrother: J. Path. Bact. 33, 17 (1930).CrossRefGoogle Scholar
  78. 78.
    Hummeler, K., D. Kirk, and M. Ostapiak: Aseptic meningitis caused by Coxsackie virus with isolation of virus from cerebrospinal fluids. J. Amer. med. Ass. 156, 676–679 (1954).CrossRefGoogle Scholar
  79. 79.
    Hummeler, K., Viruses in search of disease. Discussion part. I. Ann. N. Y. Acad. Sci. 67, 248–249 (1957).Google Scholar
  80. 80.
    La myalgie épidémique en Suède. Bull. off. int. Hyg. 26, 1083 (1934).Google Scholar
  81. 81.
    Itoh, H., and J. L. Melnick: The infection of chimpanzees with ECHO viruses. J. exp. Med. 106, 677 (1957).PubMedCrossRefGoogle Scholar
  82. 82.
    Javett, S. N., S. Heymann, B. Mundel, W. J. Pepler, H. J. Lurie, J. Gear, V. Measvoch and Z. Kirsch: Myocarditis in the newborn infant. A study of an outbreak associated with Coxsackie B virus infection in a maternity home in Johannesburg. J. Pediat. 48, 1 (1956).PubMedCrossRefGoogle Scholar
  83. 83.
    Johnsson, T.: Laboratory infections with Coxsackie viruses. Arch. ges. Virusforsch. 5 250 (1953).PubMedCrossRefGoogle Scholar
  84. 84.
    Johnsson, T.: Family infections by Coxsackievirus. Arch. ges. Virusforsch. 5, 384–400 (1954).CrossRefGoogle Scholar
  85. 85.
    Johnsson, T.:Studies on the etiology of Bornholm disease. Arch. ges. Virusforsch. 5, 401–412 (1954).PubMedCrossRefGoogle Scholar
  86. 86.
    Johnsson, T.: The occurrence of Coxsackie virus disease in a hospital material of paralytic poliomyelitis, aseptic meningitis and Miscellaneous group of disease. Arch. ges. Virusforsch. 6, 250–261 (1955).PubMedCrossRefGoogle Scholar
  87. 87.
    Johnsson, T.: and C. Lundmark: Identification of the “Fourthtype” of poliomyelitis virus (correspondence). Lancet 1957 I, 1148.CrossRefGoogle Scholar
  88. 88.
    Johnsson, T.: A new clinical entity. Lancet 1957 I, 590.CrossRefGoogle Scholar
  89. 89.
    Jungeblut, C. W., and M. A. Stevens: Attempts to isolate poliomyelitis virus from the paralysed muscles of patients during the acute stage of the Disease. Amer. J. clin. Path. 20, 701 (1950).Google Scholar
  90. 89a.
    Kalm, H.: Zur Topik des anatom. Prozesses bei der Heine-Medinschen Krankheit. Dtsch. Z. Nervenheilk. 164, 93 (1950).Google Scholar
  91. 90.
    Karzon, D. T., A. L. Barron, W. Winkelstein jr. and S. Cohen: Isolation of ECHO virus type 6 during outbreak of seasonal aseptic meningitis. J. Amer. med. Ass. 162, 1298 (1956).CrossRefGoogle Scholar
  92. 91.
    Kersting, G., H. Lennartz, U. H. Pette: Zur Pathogenese der experimentellen Poliomyelitis. I. Mitteilung. Der Virusgehalt des Liquors. Dtsch. Z. Nervenheilk. 175, 72–86 (1956).Google Scholar
  93. 92.
    Kersting, G., H. Lennartz, U. H. Pette: Neuere Untersuchungen zur Pathogenese der Poliomyelitis. Münch, med. Wschr. 98, 1684–1688 (1956).Google Scholar
  94. 93.
    Kibrick, S., and K. Bernischke: Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with Coxsackie virus Group B Type 3. New. Engl. med. J. 255, 883 (1956).CrossRefGoogle Scholar
  95. 94.
    Kibrick, S., L. Melendez and J. F. Enders: Clinical associations of enteric viruses with particular reference to agents exhibiting properties of the ECHO group. Ann. N. Y. Acad. Sci. 67, 311 (1957).PubMedCrossRefGoogle Scholar
  96. 95.
    Kibrick, S. and K. Bernischke: Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to Coxsackie virus group B. Pediatrics 22, 857 (1958).PubMedGoogle Scholar
  97. 96.
    Kochs, H.: Zur oralen Schutzimpfung gegen Poliomyelitis in West-Berlin 1960. Bundesgesundheitsblatt 10, 149 (1961).Google Scholar
  98. 97.
    Landsteiner, K., and E. Popper: Microscopic specimen from one human and two monkey spinal cords. Wien. klin. Wschr. 21, 1830 (1908).Google Scholar
  99. 98.
    McLean, D.M., C. C. Croft, J. T. Prince and E. E. Heckman: Coxsackie- and ECHO infections in Ohio during 1956. Ohio St. med. J. 53, 907 (1957).Google Scholar
  100. 99.
    McLean, D.M., S. J. Walker and G. A. McNaughton: Enterovirus infections in Toronto 1959. canad. med. Ass. J. 82, 661–665 (1960).Google Scholar
  101. 100.
    Ledinko, N., and J. L. Melnick: Interference between poliomyelitis viruses in tissue culture. J. exp. Med. 100, 247–267 (1954).PubMedCrossRefGoogle Scholar
  102. 101.
    Lehan, P. H., E. W. Chick, J. L. Doto, T. D. Y. Chin, R. H. Heeren and M. L. Furcolow: An epidemic illness associated,with a recently recognized enteric virus, ECHO virus type 4. Amer. J. Hyg. 66, 63 (1957).PubMedGoogle Scholar
  103. 102.
    Lennartz, H., U. F. Müller: Zur Frage der stummen Feiung gegen Poliomyelitis im Kindesalter. Serologische Untersuchungen bei Hamburger Kindern. Dtsch. med. Wschr. 81, 379–381 (1956).PubMedCrossRefGoogle Scholar
  104. 103.
    Lennartz, H., H. Pette, G. Kersting U. K. Mannweiler: Untersuchungen über den Einfluß des Cortisons auf Empfänglichkeit und Infektionsablauf. II. Mitteilung. Zbl. Bakt., I. Abt. Orig. 167, 9–15 (1956).Google Scholar
  105. 104.
    Lennartz, H., G. Maass U. G. Kersting: Zur Ätiologie der abakteriellen Meningitis. Ergebnisse einer virologischen Untersuchung der Meningitis-Epidemien im Sommer und Herbst 1956. Klin. Wschr. 35, 327–334 (1957).PubMedCrossRefGoogle Scholar
  106. 105.
    Lennartz, H., Coxsackie- und ECHOvirusisolierungen 1958. Zbl. Bakt., I. Abt. Orig. 176, 385–389 (1959).Google Scholar
  107. 106.
    Lennartz, H., O. Palacios U. W. Höpken: Biologische und pathogenetische Eigenschaften in Gtewebekultur isolierter Coxsackiestämme. Z. Hyg. 147, 569–580 (1961).CrossRefGoogle Scholar
  108. 107.
    Lennartz, H., P. A. Fischer U. K. Niedermeyer: Zur Frage von Folgeerscheinungen von Coxsackie-Infektionen. Fortschr. Neurol. Psychiat. 29, 319–331 (1961).PubMedGoogle Scholar
  109. 108.
    Lennartz, H., u. L. Valenciano: Virologische Untersuchungen zur oralen Schutzimpfung gegen Poliomyelitis in West-Berlin 1960.Google Scholar
  110. 109.
    Lennette, E. H., R. L. Magaffin, N. J. Schmidt and A. C. Hollister: Viral disease of the central Nervous system. Amer. J. Hyg. 65, 344 (1957).Google Scholar
  111. 110.
    Lennette, E. H.: Viral disease of the central nervous system. J. Amer. med. Ass. 171, 1456 (1959).CrossRefGoogle Scholar
  112. 111.
    Lustig, E. S. de: Interference entre les virus de Coxsackie et de poliomyelitis sur les cultures de HeLa. C. R. Soc. Biol. (Paris) 15, 2017–2018 (1956).Google Scholar
  113. 112.
    Lwoff, A.: Factors in evolution of viral disease. Bact. Rev. 23, 123 (1959).Google Scholar
  114. 113.
    Melnick, J. L., and A. S. Kaplan: Dual antibody response to Coxsackie and polio-myelitis virus in patients with paralytic poliomyelitis. Proc. Soc. Biol. (N. Y.) 74, 812–815 (1950).Google Scholar
  115. 114.
    Melnick, J. L., A. S. Kaplan, E. Zabin, G. Contreras and N. W. Larkum: An epidemic of paralytic poliomyelitis characterized by dual infections with poliomyelitis and Coxsackie virus. J. exp. Med. 94, 471–492 (1951).PubMedCrossRefGoogle Scholar
  116. 115.
    Melnick, J. L.: Problems associated with viral identification and classification in 1956. Ann. N. Y. Acad. Sci. 67, 363–382 (1957).PubMedCrossRefGoogle Scholar
  117. 116.
    Melnick, J. L.: ECHO viruses in cellular biology, nucleids and viruses (special publication). Ann. N. Y. Acad. Sci. 5, 365 (1957).Google Scholar
  118. 117.
    Melnick, J. L.: Advances in the study of the enteroviruses. Progr. med. Virol. 1, 59 (1958).Google Scholar
  119. 118.
    Melnick, J. L.: and M. Benyesh-Melnick: Problems associated with live poliovirus vaccine and its progent after multiplication in man. 22. 30. Live Poliovirus Vaccine World Health. Org. Washington, D.C. 1960.Google Scholar
  120. 119.
    Montgomery, J., J. Gear, F. Prinsloo, M. Kahn and Z. G. Kirsch: Myocarditis of the newborn. An outbreak in a maternity home in Southern Rhodesia associated with Coxsackie B virus infection. S. Afr. med. J. 29, 608 (1955).PubMedGoogle Scholar
  121. 120.
    Neva, F. A., R. F. Feemster and J. I. Gorbach: Clinical and epidemiologic features of an unusual epidemic exanthem. J. Amer. med. Ass. 155, 544 (1954).CrossRefGoogle Scholar
  122. 121.
    Neva, F. A.: A second outbreak of Boston exanthem disease in Pittsburgh during 1954. New Engl, med. J. 254, 838 (1956).Google Scholar
  123. 122.
    Neva, F. A. and S. M. Zuffante: Agents isolated from Boston exanthem disease during 1954 in Pittsburgh. J. Lab. clin. Med. 50, 712 (1957).PubMedGoogle Scholar
  124. 123.
    Nihottl, E., L. Quersin and A. Weynants: ECHO virus type 9 as the agent responsible for an important outbreak of aseptic meningitis in Belgium. Amer. J. Hyg. 66, 102 (1957).Google Scholar
  125. 124.
    Oldershausen, H.-F. von, L. Grützner u. G. Friedebold: Über poliomyelitisähnliche paretische Verlaufsformen nach Echo-Infektionen. Klin. Wschr. 38, 923 (1960).CrossRefGoogle Scholar
  126. 125.
    Parrott, R. H.: The clinical importance of group A Coxsackie viruses. Ann. N. Y. Acad. Sci. 67, 230–239 (1957).PubMedCrossRefGoogle Scholar
  127. 126.
    Pette, H.: Beitrag zur Frage der “Febris herpetica (Meningitis herpetica ?)” Acta med. scand. LXX, 421 (1929).Google Scholar
  128. 127.
    Pette, H.: Tierexperimentelle Studien zur Frage der Viruswanderung im Nervensystem. Teil I, II, III. Dtsch. Z. Nervenheilk. 121, 113–164 (1931).CrossRefGoogle Scholar
  129. 128.
    Pette, H., H. Demme U. ST. Környey: Studien über experimentelle Poliomyelitis. Dtsch. Z. Nervenheilk. 128, 125 (1932).CrossRefGoogle Scholar
  130. 129.
    Pette, H., G. Kersting, H. Lennartz u. G. Maass: III. Mitteilung. Virusausbreitung bei oraler Infektion, Einfluß von Cortison und Röntgenbestrahlung auf Empfänglichkeit und In-fektionsverlauf. Zbl. Bakt., I. Abt. Orig. 167, 419–426 (1957).Google Scholar
  131. 130.
    Pette, H., G. Maass, L. Valenciano u. K. Mannweiler: Zur Frage der Neuropathogenität von Enteroviren. Arch. ges. Virusforschung. X. 408 (1960).Google Scholar
  132. 131.
    Pette, H., G. Maass, L. Valenciano U. K. Mannweiler: Tierexperimentelle Untersuchungen zur Neuropathogenität der ECHO virustypen 4, 6, und 16. Klin. Wschr. 38, 5, 916 (1960).PubMedCrossRefGoogle Scholar
  133. 132.
    Pette, H., H. Lennartz, G. Maass, L. Valenciano and K. Mannweiler: Experimental studies on animals with attenuated polio virus (Cox and Sabin strains). Libe Polio virus Vaccines. World Health Org., Washington, D. C. 1960. 68–78.Google Scholar
  134. 133.
    Ramos-Alvarez, M., and A. B. Sabin: Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children. Proc. Soc. exp. Biol. (N. Y.) 87, 655 (1954).Google Scholar
  135. 134.
    Ramos-Alvarez, M., and A. B. Sabin: Intestinal viral flora of healthy children demonstrable by monkey kidney tissue culture. Amer. J. publ. Hlth. 46, 295 (1956).CrossRefGoogle Scholar
  136. 135.
    Ramos-Alvarez, M., and A. B. Sabin: Cytopathogenic enteric virus associated with undifferentiated diarrheal syndromes in early childhood. Ann. N. Y. Acad. Sci. 67, 326 (1957).PubMedCrossRefGoogle Scholar
  137. 136.
    Ramos-Alvarez, M., and A. B. Sabin: Role of enteropathogenic viruses and bakteria in summer diarrheal diseases of infancy and early childhood. J. Amer. med. Ass. 167, 147 (1958).CrossRefGoogle Scholar
  138. 137.
    Ranzenhofer, E. R., F. C. Dizon, M. M. Lipton and A. J. Steigman: Clinical paralytic poliomyelitis due to Coxsackie virus group A. New. Engl. med. J. 259, 182–184 (1958).CrossRefGoogle Scholar
  139. 138.
    Rhodes, A. J., and A. J. Beale: Aseptic meningitis evidence of etiologic role of Coxsackie B and orphan viruses. Ann. N. Y. Acad. Sci. 67, 212–222 (1957).PubMedCrossRefGoogle Scholar
  140. 139.
    Rosen, L., J. H. Johnsson, R. J. Hübner and J. A. Bell: Observation on a newly recognized ECHO virus and a discription of an outbreak in a nursery. In Druck (1958).Google Scholar
  141. 140.
    Rossi, E., M. Rentsch and u. Krech: Die poliomyelitisähnlichen paretischen Erkrankungen. Schweiz, med. Wschr. 89, 688 (1959).Google Scholar
  142. 141.
    Sabin, A. B., and R. Ward: The natural history of human poliomyelitis. I. Distribution of virus in nervus and non-nervous tissues. J. exp. Med. 73, 771 (1941).PubMedCrossRefGoogle Scholar
  143. 142.
    Sabin, A. B.: Behaviour of chimpanzees — avirulent poliomyelitis viruses in experimentally infected human volunteers. Amer. J. med. Sci. 230, 1 (1955).PubMedCrossRefGoogle Scholar
  144. 143.
    Sabin, A. B.: Pathogenesis of poliomyelitis. Reappraisal in the light of new data. Science 123, 1151–1152 (1956).PubMedCrossRefGoogle Scholar
  145. 144.
    Sabin, A. B.: The role of ECHO viruses in human disease. In: “Viral infections of infancy and childhood.” p. 78. Sympos. No. 10 on Microbiol. N. Y. Acad. Med. 1958.Google Scholar
  146. 145.
    Sabin, A. B.: Symposion Viruses. Current advances with clinical applications. Mod. Med. (Minneap. 94, 58 (1958).Google Scholar
  147. 146.
    Sabin, A. B., R. Wigand and H. D. Smith: Etiology of summer febrile illnesses with rash in Cincinnati in 1957. In Druck. (1958).Google Scholar
  148. 147.
    Sabin, A. B., E. R. Krumbiegel and R. Wigand: Virologically controlled clinical epidemiologic observations during 1957 epidemic in Milwaukee with notes on concurrent somilar diseases associates with Coxsackie and other ECHO viruses. Amer. J. Dis. Child. 96, 197 (1958).Google Scholar
  149. 148.
    Sabin, A. B.: Live Poliovirus Vaccines, 14. Wld. Hlth. Org. Washington, D. C. 1959.Google Scholar
  150. 149.
    Salk, J. E.: A concept of the mechanism of immunity for preventing paralysis in polio-myelitis. Ann. N. Y. Acad. Sci. 61, 1023 (1955).PubMedCrossRefGoogle Scholar
  151. 150.
    Shwartzman, G., S. M. Aronson, C. V. Teodoru, M. Adler, and R. Jaheil: Endocrinological aspects of pathogenesis of experimental poliomyelitis. Ann. N. Y. Acad. Sci. 61, 869 (1955).PubMedCrossRefGoogle Scholar
  152. 151.
    Sheffield, F. W., and G. M. Churcher: The serial propagation of poliomyelitis virus in cells derived from rabbit embryo kidney. Brit. J. exp. Path. 38, 155–159 (1957).PubMedGoogle Scholar
  153. 152.
    Sickles, G. M.: New tipes of Coxsackie virus group A. Cytopathogenicity in tissue culture. Proc. Soc. exp. Biol. (N. Y.) 102, 742 (1959).Google Scholar
  154. 153.
    Sommerville, R. G.: Interference phenomena between ECHO virustypes 1, 2, 7 and 11. Arch. ges. Virusforsch. X, 1 (1959).Google Scholar
  155. 154.
    South Africa Institute for Medical Research: Annual report, pp. 49–51, 54–57, 1955/56.Google Scholar
  156. 155.
    Stanley, N. F., D. C. Dorman and J. Ponsford: A hitherto undescribed group of Coxsackie viruses associeted with an outbreak of encephalitis. Aust. J. exp. Biol. med. Sci. 31, 31 (1953).PubMedCrossRefGoogle Scholar
  157. 156.
    Steigmann, A. J., V. P. Kokko and R. J. Silverberg: Unusual properties of a virus isolated from the spinal cord of a child with fatal poliomyelitis. Amer. J. Dis. Child. 86, 509 (1953).Google Scholar
  158. 157.
    Steigmann, A. J.: Viruses in search of disease. Ann. N. Y. Acad. Sci. 67, 249 (1957).Google Scholar
  159. 158.
    Sylvest, E.: Epidemic myalgia, Bornholm disease. London: Humphrey Milford: Oxford Univ. Press. 1934.Google Scholar
  160. 159.
    Syverton, J. T.: An appraisal of the enterovirus problem. Amer. J. trop. Med. 8, 101–109. (1959).PubMedGoogle Scholar
  161. 160.
    Thieffry, S., M. Arthius, Ch. Martin, J. Celers, V. Drouhet et A. Boué: Etude clinique et sérologique systématique de 473 cas d’affections du système nerveux par les entérovirus (Poliomyélite, Coxsackie, ECHO). 1.–26. Association Européenne contre la Poliomyélite, VII. Symposium, 17–20. Sept. Oxford, 1960. (1961).Google Scholar
  162. 161.
    Todorovic, K.: In: Virus Meningo-Encephalitis, General Discussion. Cibe Foundation Study Group No. 7. p. 106. London: J. & A. Churchill Ltd. 1961.Google Scholar
  163. 162.
    Toshiako, Komae: Studies on Coxsackie viruses isolated from cases of polyradiculoneuritis — socalled Guillain-Barré-Syndrome. J. Virol. 8, 83 (1958).Google Scholar
  164. 163.
    Tyrell, D. A. J.: Recovery of a virus from cases of an epidemic exanthem associated with meningitis. Lancet 1956 II, 1028–1029.CrossRefGoogle Scholar
  165. 164.
    Tyrell, D. A. J., S. K. R. Clarke, K. B. Heath and R. C. Curran: Studies of the Coxsackie virus antigenically related to ECHO 9 virus and associated with an epidemic of aseptic meningitis with exanthem. Brit. J. exp. Path. 34, 178 (1958).Google Scholar
  166. 165.
    Verlinde, J. D., A. Kret and R. Wyler: The distribution of poliomyelitis virus in cynomolgus monkeys following oral administration. Arch. ges. Virusforsch. 6, 175 (1955).PubMedCrossRefGoogle Scholar
  167. 166.
    Verlinde, J. D.: Myocarditis in newborn due to group B Coxsackie virus. Ann. paediat. (Basel) 187, 113 (1956).Google Scholar
  168. 167.
    Verlinde, J. D., In: Poliomyelitis: Paper and discussions presented at the 4 int. Poliomyelitis Confrence. Philadelphia and Montreal: J. B. Lippincott 1958.Google Scholar
  169. 168.
    Verlinde, J. D., and J. B. Wilterdink: Neuropathogenicity of nonpolio-enteroviruses with special reference to ECHO 9 virus. Folia psychiat. neerl. 61, 670 (1958).PubMedGoogle Scholar
  170. 169.
    Verlinde, J. D., J. B. Wilterdink, and R. P. Mouton: Presence of two interfering intero viral agents (ECHO virus type 9 and polio virus type 2) in the human central nervous system. Arch. ges. Virusforsch. X, 399 (1961).Google Scholar
  171. 170.
    Weigand, H.: Die gegenScitigen Beziehungen der Enteroviren. Dtsch. med. Wschr. 85, 9, 357 (1960).PubMedCrossRefGoogle Scholar
  172. 171.
    Weinstein, S. B.: Acute benign pericarditis associated with Coxsackie virus group B type 5. New Engl. J. med. 257, 265 (1957).PubMedCrossRefGoogle Scholar
  173. 172.
    Weinstein, L.: Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis. New Engl. J. Med. 257, 47–52 (1957).PubMedCrossRefGoogle Scholar
  174. 173.
    Wenner, H. A., and T. D. Y. Chin: IV. Intern. Polio-Congr. Geneva, Switzerland 1957.Google Scholar
  175. 174.
    Wiesmann, E., and T. Wegmann: Bemerkungen zu poliomyelitisähnlichen Erkrankungen. Schweiz, med. Wschr. 89, 694 (1959).Google Scholar
  176. 175.
    Wiesmann, E.: Evaluation of poliovaccination with Lederle-Cox-Triple-Vaccine in the North-East of Switzerland, pp. 95–98. European Association against Poliomyelitis. VII. Symposium Oxford 17-. 20. September 1961.Google Scholar
  177. 176.
    Windorfer, A., and D. Reiss: Die Bornholmer Krankheit (Myalgia epidemica (Sylvest)). Ergebn. inn. Med. Kinderheilk. 13, 243 (1960).Google Scholar
  178. 177.
    Zahorsky, J.: Herpetic sore throat. S. Afr. med. J. 13, 871 (1920).Google Scholar
  179. 178.
    Zahorsky, J.: Herpangina (a specific infections disease). Arch. Pediat. 41, 181–184 (1924).Google Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1963

Authors and Affiliations

  • Hilt Lennartz

There are no affiliations available

Personalised recommendations